Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sociocultural factors influencing alcohol use among Korean immigrant women: A scoping review.

PloS one·2026
Same author

Statistical analysis of disease onset during lifespan with left truncation.

Biometrics·2026
Same author

Obstructive Sleep Apnea in Critically Ill Patients: A Structured Narrative Review of Prevalence, Diagnostic Barriers, and Clinical Implications in the ICU.

Clocks & sleep·2026
Same author

Trajectories of reproductive events from menarche to menopause: identifying patterns and differences by childhood maltreatment and socioeconomic position.

American journal of epidemiology·2026
Same author

Exercise Habits, Preferences, Barriers, and Facilitators in Midlife Women.

Exercise, sport & movement·2026
Same author

Nulato.

The Journal of medical humanities·2026

Related Experiment Videos

Does hormone therapy affect blood pressure changes in the Diabetes Prevention Program?

Catherine Kim1, Sherita H Golden, Shengchun Kong

  • 1From the 1Department of Medicine and Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI; 2Department of Medicine, Johns Hopkins University, Baltimore, MD; 3Department of Biostatistics, University of Michigan, Ann Arbor, MI; 4Department of Medicine, Indiana University, Indianapolis, IN; and 5Department of Preventive Medicine, University of California San Diego, La Jolla, CA.

Menopause (New York, N.Y.)
|August 15, 2013
PubMed
Summary

Postmenopausal estrogen use does not affect blood pressure reductions from intensive lifestyle change (ILS) in overweight women with glucose intolerance. Metformin also showed no significant blood pressure benefits.

Related Experiment Videos

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Health
  • Women's Health

Background:

  • Overweight women with glucose intolerance are at increased risk for hypertension.
  • The role of postmenopausal estrogen therapy in cardiovascular risk modification requires further investigation.
  • Understanding factors influencing blood pressure control is crucial for preventing cardiovascular events.

Purpose of the Study:

  • To investigate whether blood pressure reductions differ based on postmenopausal estrogen use among overweight, glucose-intolerant women.
  • To analyze the impact of intensive lifestyle change (ILS) and metformin on blood pressure in relation to estrogen therapy.
  • To explore associations between blood pressure changes and sex hormone levels.

Main Methods:

  • Secondary analysis of Diabetes Prevention Program participants (n=706) categorized by oral estrogen use at baseline and 1-year follow-up.
  • Comparison of systolic blood pressure (SBP) and diastolic blood pressure (DBP) changes across ILS, metformin, and placebo arms.
  • Examination of correlations between blood pressure changes and alterations in sex hormone-binding globulin, estradiol, and testosterone.

Main Results:

  • Estrogen users and nonusers exhibited similar baseline hypertension prevalence and medication use.
  • Both groups showed comparable SBP and DBP reductions with ILS compared to placebo.
  • Metformin did not significantly reduce blood pressure, irrespective of estrogen therapy status.

Conclusions:

  • Intensive lifestyle change effectively reduces blood pressure in overweight women with dysglycemia, independent of postmenopausal estrogen use.
  • Metformin did not demonstrate significant blood pressure-lowering effects in this population.
  • Blood pressure changes were not associated with alterations in measured sex hormones.